B
BioLine Rx
BLRX
Reported
Tuesday, May 27
Q1 2025 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -1.06 | 0.00 | 1.06 | 100.09% |
| Revenue | 1.48M | 255K | -1.23M | -82.77% |
WhatIF - Earnings
EPS Beat Expectations by $1.06
BioLine Rx (BLRX:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything